XS2592804194 · Corp · EUR

Teva Pharmaceutical Finance Nether 7.88% 2031/09

MID PRICE
137.64
par = 100
YIELD TO MAT.
4.35%
semi-annual
COUPON
7.880%
semi-annual · fixed
MATURITY
2031-09-15
bullet · 5.37y
OUTSTANDING
not disclosed
AS OF
2026-05-01
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.42 y
1bp ↑ ≈ -0.044% P&L
Convexity
23.91
higher = more curvature
Years to maturity
5.37 y
YTM source
Ingested
Fund disclosure
G-spread
+154 bps
vs ECB AAA curve · 2026-04-29
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Global High Yield Corporate Bond
iShares
Global HY Corporate$139K▲ $4620.07%2026-05-01
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-01

Institutional footprint · signal-level holdings

0/ 100
Interpretation. Thin coverage — below signal threshold
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$139K
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
137,640 EUR
161,067 USD
FX SOURCE
ECB · CoinGecko
PRICE
137.64

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 7 7/8 09/15/31
FIGI
BBG01FNWDHC4
ISIN
XS2592804194
Type
Corp
Issued
2023-03-09
Face value
100 EUR
Ticker
TEVA 7.875 09/15/31
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

TEVA · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.